Algicid Plus 200 ml

ncy & Lactation

Pregnancy: Clinical studies in more than 500 pregnant women as well as a large amount of data from post-marketing experience indicate no malformative nor feto/neonatal toxicity of the active substances. This drug can be used during pregnancy, if clinically needed.

Breast feeding: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breast-feeding.

Fertility: Pre-clinical investigations have revealed alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.

Precautions & Warnings

If symptoms do not improve after seven days, the clinical situation should be reviewed. Each 10 ml dose has a sodium content of 141 mg (6.2 mmol). This should be taken into account when a highly restricted salt diet is recommended. e.g. in some cases of congestive cardiac failure and renal impairment. Each 10 ml dose contains 160 mg (1.6 mmol) of calcium carbonate. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.

Therapeutic Class

Antacids

Storage Conditions

Do not store above 30°C. Do not refrigerate or freeze.

Pharmaceutical Name

Incepta Pharmaceuticals Ltd